[HTML][HTML] Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis

RB Mrid, N Bouchmaa, H Ainani, R El Fatimy… - Biomedicine & …, 2022 - Elsevier
Rheumatoid arthritis (RA) is one of more than 100 types of arthritis. This chronic autoimmune
disorder affects the lining of synovial joints in about 0.5% of people and may induce severe …

Tuberculosis and biologic therapies: anti-tumor necrosis factor-α and beyond

MS Godfrey, LN Friedman - Clinics in chest medicine, 2019 - chestmed.theclinics.com
Tumor necrosis factor-alpha (TNF-a) is involved in the pathogenesis of several inflammatory
diseases such as rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis, and …

Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC …

J Kron, T Crawford, V Mihalick, F Bogun… - Journal of Translational …, 2021 - Springer
Background Sarcoidosis is an inflammatory disease characterized by the formation of
granulomas, which involve the heart in up to 25% of patients. Cardiac sarcoidosis can lead …

Systemic rheumatic diseases: from biological agents to small molecules

P Sarzi-Puttini, A Ceribelli, D Marotto, A Batticciotto… - Autoimmunity …, 2019 - Elsevier
The development of biologics and small oral molecules has recently changed the scenario
of pharmacologic treatment of systemic rheumatic diseases and it has become a real …

The diversity outbred mouse population is an improved animal model of vaccination against tuberculosis that reflects heterogeneity of protection

SL Kurtz, AP Rossi, GL Beamer, DM Gatti, I Kramnik… - Msphere, 2020 - Am Soc Microbiol
Many studies of Mycobacterium tuberculosis infection and immunity have used mouse
models. However, outcomes of vaccination and challenge with M. tuberculosis in inbred …

Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task

G Ni, L Zhang, X Yang, H Li, B Ma… - Human vaccines & …, 2020 - Taylor & Francis
ABSTRACT Interleukin 10 (IL-10) belongs to IL-10 family cytokines that are critical for
maintaining the integrity of epithelial tissues, protecting pathogenic infection, and preventing …

[HTML][HTML] Paradoxical reactions to biologicals in chronic inflammatory systemic diseases

I Kremenevski, O Sander, M Sticherling… - Deutsches Ärzteblatt …, 2022 - ncbi.nlm.nih.gov
Background Biological agents that contain substances affecting the immune system are
increasingly being used to treat chronic inflammatory systemic diseases. Aside from the …

Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists

G Fromm, S de Silva, TH Schreiber - Frontiers in Immunology, 2023 - frontiersin.org
The extracellular domain of tumor necrosis factor receptors (TNFR) generally require
assembly into a homotrimeric quaternary structure as a prerequisite for initiation of signaling …

Treatment of Parkinson's disease with biologics that penetrate the blood–brain barrier via receptor-mediated transport

WM Pardridge - Frontiers in Aging Neuroscience, 2023 - frontiersin.org
Parkinson's disease (PD) is characterized by neurodegeneration of nigral-striatal neurons in
parallel with the formation of intra-neuronal α-synuclein aggregates, and these processes …

Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (Chiloscyllium plagiosum)

L Zhao, M Chen, X Wang, S Kang, W Xue, Z Li - Marine Drugs, 2022 - mdpi.com
Tumor necrosis factor α (TNFα), an important clinical testing factor and drug target, can
trigger serious autoimmune diseases and inflammation. Thus, the TNFα antibodies have …